EcoDrugPlus

G Protein-Coupled Receptor 119

Ensembl ID : ENSLCRG00005015018
Gene Symbol: GPR119
3 Cross references
174 Possible Orthologues:

G-Box-Binding Factor

Ensembl ID : ENSLCRG00005007564
Gene Symbol: SI:CH211-79M20.1
2 Cross references
190 Possible Orthologues:

G-Protein Coupled Receptor 84

Ensembl ID : ENSLCRG00005002065
Gene Symbol: LOC109136688
3 Cross references
124 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSLCRG00005020401
Gene Symbol: HCK
3 Cross references
202 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSLCRG00005001339
Gene Symbol: ITK
3 Cross references
205 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 1a

Ensembl ID : ENSLCRG00005012315
Gene Symbol: IMPDH1A
3 Cross references
258 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 2

Ensembl ID : ENSLCRG00005019574
Gene Symbol: IMPDH2
3 Cross references
200 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSLCRG00005005113
Gene Symbol: JAK1
3 Cross references
212 Possible Orthologues:

Janus Kinase 2a

Ensembl ID : ENSLCRG00005012127
Gene Symbol: JAK2A
3 Cross references
199 Possible Orthologues:

Janus Kinase 2b

Ensembl ID : ENSLCRG00005002205
Gene Symbol: JAK2B
3 Cross references
194 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase B

Ensembl ID : ENSLCRG00005012510
Gene Symbol: KITB
3 Cross references
200 Possible Orthologues:

Lyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSLCRG00005019943
Gene Symbol: LYN
3 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).